Tristar BMT

Nashville, Tennessee 37203

4 studies enrolling now · 5 studies all time

What they study most

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Advanced Cancer, Advanced Malignancies, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase, Diffuse Large B Cell Lymphoma

Studies at this site

• Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) — Recruiting now
• A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms — Recruiting now
• An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers — Recruiting now
• A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) — Recruiting now
• HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide — Running, not enrolling